In conclusion, our results indicated that TAZ enhances GPX4-mediated ferroptosis resistance in BLCA cells by establishing a positive feedback loop with NRF2, thereby promoting the malignant progression of BLCA. Here, GPX4 is linked to bladder transitional cell carcinoma.